Goat Anti-Human IgM, Mouse/Bovine/Horse SP ads-UNLB
Cat. No.:
2023-01
Purified Goat Anti-Human IgM antibody with minimal reactivity to mouse, bovine, and horse serum proteins for use in ELISA assays.
$111.00
| Isotype | Goat IgG |
|---|---|
| Isotype Control | Goat IgG-UNLB |
| Specificity | Reacts with the heavy chain of human IgM |
| Source | Pooled antisera from goats hyperimmunized with human IgM |
| Cross Adsorption | Human IgG and IgA; mouse, bovine, and horse serum proteins (SP); may react with IgM from other species |
| Purification Method | Affinity chromatography on human IgM covalently linked to agarose |
| Conjugate | UNLB (Unconjugated) |
| Buffer Formulation | Borate buffered saline, pH 8.2 |
| Clonality | Polyclonal |
| Concentration | 1.0 mg/mL |
| Volume | 1.0 mL |
| Recommended Storage | 2-8°C |
| Applications |
Quality tested applications for relevant formats include - ELISA 1-4 FLISA |
| RRID Number | AB_2795619 |
| Gene ID |
3507 (Human) |
| Gene ID Symbol |
IGHM (Human) |
| Gene ID Aliases | AGM1; MU; VH |
| UniProt ID |
P01871 (Human) |
| UniProt Name |
IGHM_HUMAN (Human) |
Documentation
Certificate of Analysis Lookup
Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view
- 1. Magnani DM, Rogers TF, Beutler N, Ricciardi MJ, Bailey VK, Gonzalez-Nieto L, et al. Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques. Sci Transl Med. 2017;9:eaan8184. (ELISA)
- 2. Isho B, Abe KT, Zuo M, Jamal AJ, Rathod B, Wang JH, et al. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients. Sci Immunol. 2020;5:eabe5511. (ELISA)
- 3. Honjo K, Russell RM, Li R, Liu W, Stoltz R, Tabengwa EM, et al. with humoral immunodeficiency. Cell Rep Med. 2020;2:100164. (ELISA)
- 4. Zhang B, Huo J, Huang Y, Teo SY, Duan K, Li Y, et al. mRNA booster vaccination enhances antibody responses against SARS-CoV2 omicron variant in individuals primed with mRNA or inactivated virus vaccines. Vaccines (Basel). 2022;10:1057. (ELISA)
See More


















